TAVRA Biosciences is a biotech company that offers cGMP‑manufactured stem cell products for the treatment of inflammation and injuries.
TAVRA Biosciences has raised $300K in total funding. The most recent round was Seed. The last funding was announced in April 2026.
TAVRA Biosciences is headquartered in Plano, United States.
TAVRA Biosciences is a biotech company that offers cGMP‑manufactured stem cell products for the treatment of inflammation and injuries.
TAVRA Biosciences is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TAVRA Biosciences — Funding & Investors." VCBacked, April 15, 2026, https://www.vcbacked.co/company/tavra-biosciences. Accessed August 14, 2026.
VCBacked. (2026). TAVRA Biosciences — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/tavra-biosciences
{{cite web |title=TAVRA Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/tavra-biosciences |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated